ArticlePloS one2026
Cognitive function is associated with risk of conversion to secondary progressive multiple sclerosis: A cross-sectional study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPredicting conversion from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) is critical for managing people with multiple sclerosis (PwMS). Cognitive function has been linked to disease progression in RRMS, yet its association with conversion to SPMS remains underexplored. This study aimed to assess this relationship using the newly developed DAAE score to calculate the risk of conversion to SPMS.
methodsThe risk of conversion over five years was assessed using the DAAE score (0-12), and the PwMS were categorized into very-low-to-low and medium-to-high risk groups. Cognitive function was assessed using the Symbol Digit Modalities Test (SDMT), Brief Visuospatial Memory Test-Revised (BVMT-R), Paced Auditory Serial Addition Test (PASAT), and California Verbal Learning Test-Second Edition (CVLT-II). Pairwise correlations and hierarchical linear and logistic regression analyses were performed to examine the relationship between cognition and conversion risk.
resultsA total of 217 PwMS were included (very low to low = 185, medium to high = 32). The DAAE score was moderately correlated with SDMT and BVMT-R and weakly correlated with PASAT and CVLT-II. Multivariable linear regressions found SDMT (beta = -0.125, 95%CI: -0.155, -0.096, p-value < 0.001), BVMT-R (beta = -0.157, 95%CI: -0.200, -0.114, p-value < 0.001), PASAT (beta = -0.084, 95%CI: -0.111, -0.057, p-value < 0.001), and CVLT-II (beta = -0.088, 95%CI: -0.125, -0.050, p-value < 0.001) were independently associated with the risk of conversion. Among these, SDMT (beta = -0.093, 95% CI: -0.133 to -0.054, p-value < 0.001) was the most robust predictor of conversion risk.
conclusionIn conclusion, low cognitive performance across the BICAMS battery and the PASAT, with the SDMT as the most robust predictor, is associated with an increased risk of conversion from RRMS to SPMS. By demonstrating this association through a machine-learning framework, the present study supports the integration of standardized neuropsychological assessments into routine clinical practice as tools for monitoring conversion risk in PwMS, beyond conventional clinical measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.